Indication
SHINGRIX Vaccine Response Rates
1 clinical trial
1 product
Clinical trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients That Are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) TherapyStatus: Completed, Estimated PCD: 2020-09-09